INTERNATIONAL PATENT: ABALYTICS ONCOLOGY, INC. FILES APPLICATION FOR "ANTI-PD-1 ANTIBODIES AND RELATED BINDING MOLECULES AND METHODS AND USES THEREOF"

GENEVA, Nov. 26 -- ABALYTICS ONCOLOGY, INC. (1 Franklin Street, Unit 5304Boston, Massachusetts 02110) filed a patent application (PCT/US2025/029446) for "ANTI-PD-1 ANTIBODIES AND RELATED BINDING MOLECULES AND METHODS AND USES THEREOF" on May 14, 2025. With publication no. WO/2025/240670, the details related to the patent application was published on Nov 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): PAINTAL, Akshay (7430 Mason LaneFalls Church, Virginia 22042)

Abstract: Provided are novel monoclonal antibodies or antibody fragments against protein programmed cell death 1 (PD-1). The an...